Cumberland Pharmaceuticals(CPIX) - 2023 Q1 - Quarterly Report

Joint Venture Agreement (8) OTHER INCOME Cumberland is a party to several collaborative arrangements with research institutions to identify and pursue promising pharmaceutical product candidates. The funding for these programs is primarily provided through Federal Small Business Administration (SBIR/STTR) and other grant awards. The Company has determined that these collaborative agreements, with the exception of the collaborative payment received related to RediTrex, do not meet the criteria for accounting ...